The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors

Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the nerve, even benign tumors are often difficult to remove by surgery. In addition, the majority of neural tumors are malignant, and it is particular the...

Full description

Saved in:
Bibliographic Details
Published inMolecular cancer Vol. 20; no. 1; pp. 49 - 16
Main Authors Zheng, Yiyang, Luo, Yanyan, Chen, Xixi, Li, Huiting, Huang, Baojun, Zhou, Baofeng, Zhu, Liqing, Kang, Xianhui, Geng, Wujun
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 05.03.2021
BioMed Central
BMC
Subjects
Antigens
Biomarkers
Brain cancer
Cancer
Cancer therapies
Central nervous system
Chemotherapy
Deoxyribonucleic acid
Diagnosis
DNA
DNA methylation
Exosomes
Gene expression
Gene regulation
Gene therapy
Genes
Genetic disorders
Immunotherapy
Medical diagnosis
Messenger RNA
MicroRNAs
Molecular biology
Mortality
mRNA
Mutation
Nervous system
Neural tumor
Prognosis
Proteins
R&D
Radiation therapy
Research & development
Review
Stem cells
Surgery
Tumor therapy
Tumorigenesis
Tumors
Neural tumor
mRNA
Tumor therapy
Gene regulation
Online AccessGet full text

Cover

Abstract Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the nerve, even benign tumors are often difficult to remove by surgery. In addition, the majority of neural tumors are malignant, and it is particular the same for the central nervous system tumors. Even treated with the means such as chemotherapy and radiotherapy, they are also difficult to completely cure. In recent years, an increasingly number of studies have focused on the use of mRNA to treat tumors, representing an emerging gene therapy. The use of mRNA can use the expression of some functional proteins for the treatment of genetic disorders or tissue repair, and it can also be applied to immunotherapy through the expression of antigens, antibodies or receptors. Therefore, although these therapies are not fully-fledged enough, they have a broad research prospect. In addition, there are many ways to treat tumors using mRNA vaccines and exosomes carrying mRNA, which have drawn much attention. In this study, we reviewed the current research on the role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors, and examine the future research prospects of mRNA in neural tumors and the opportunities and challenges that will arise in the future application of clinical treatment.
AbstractList Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the nerve, even benign tumors are often difficult to remove by surgery. In addition, the majority of neural tumors are malignant, and it is particular the same for the central nervous system tumors. Even treated with the means such as chemotherapy and radiotherapy, they are also difficult to completely cure. In recent years, an increasingly number of studies have focused on the use of mRNA to treat tumors, representing an emerging gene therapy. The use of mRNA can use the expression of some functional proteins for the treatment of genetic disorders or tissue repair, and it can also be applied to immunotherapy through the expression of antigens, antibodies or receptors. Therefore, although these therapies are not fully-fledged enough, they have a broad research prospect. In addition, there are many ways to treat tumors using mRNA vaccines and exosomes carrying mRNA, which have drawn much attention. In this study, we reviewed the current research on the role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors, and examine the future research prospects of mRNA in neural tumors and the opportunities and challenges that will arise in the future application of clinical treatment.
Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the nerve, even benign tumors are often difficult to remove by surgery. In addition, the majority of neural tumors are malignant, and it is particular the same for the central nervous system tumors. Even treated with the means such as chemotherapy and radiotherapy, they are also difficult to completely cure. In recent years, an increasingly number of studies have focused on the use of mRNA to treat tumors, representing an emerging gene therapy. The use of mRNA can use the expression of some functional proteins for the treatment of genetic disorders or tissue repair, and it can also be applied to immunotherapy through the expression of antigens, antibodies or receptors. Therefore, although these therapies are not fully-fledged enough, they have a broad research prospect. In addition, there are many ways to treat tumors using mRNA vaccines and exosomes carrying mRNA, which have drawn much attention. In this study, we reviewed the current research on the role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors, and examine the future research prospects of mRNA in neural tumors and the opportunities and challenges that will arise in the future application of clinical treatment.Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the nerve, even benign tumors are often difficult to remove by surgery. In addition, the majority of neural tumors are malignant, and it is particular the same for the central nervous system tumors. Even treated with the means such as chemotherapy and radiotherapy, they are also difficult to completely cure. In recent years, an increasingly number of studies have focused on the use of mRNA to treat tumors, representing an emerging gene therapy. The use of mRNA can use the expression of some functional proteins for the treatment of genetic disorders or tissue repair, and it can also be applied to immunotherapy through the expression of antigens, antibodies or receptors. Therefore, although these therapies are not fully-fledged enough, they have a broad research prospect. In addition, there are many ways to treat tumors using mRNA vaccines and exosomes carrying mRNA, which have drawn much attention. In this study, we reviewed the current research on the role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors, and examine the future research prospects of mRNA in neural tumors and the opportunities and challenges that will arise in the future application of clinical treatment.
Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the nerve, even benign tumors are often difficult to remove by surgery. In addition, the majority of neural tumors are malignant, and it is particular the same for the central nervous system tumors. Even treated with the means such as chemotherapy and radiotherapy, they are also difficult to completely cure. In recent years, an increasingly number of studies have focused on the use of mRNA to treat tumors, representing an emerging gene therapy. The use of mRNA can use the expression of some functional proteins for the treatment of genetic disorders or tissue repair, and it can also be applied to immunotherapy through the expression of antigens, antibodies or receptors. Therefore, although these therapies are not fully-fledged enough, they have a broad research prospect. In addition, there are many ways to treat tumors using mRNA vaccines and exosomes carrying mRNA, which have drawn much attention. In this study, we reviewed the current research on the role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors, and examine the future research prospects of mRNA in neural tumors and the opportunities and challenges that will arise in the future application of clinical treatment. Keywords: mRNA, Neural tumor, Tumor therapy, Gene regulation
Abstract Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the nerve, even benign tumors are often difficult to remove by surgery. In addition, the majority of neural tumors are malignant, and it is particular the same for the central nervous system tumors. Even treated with the means such as chemotherapy and radiotherapy, they are also difficult to completely cure. In recent years, an increasingly number of studies have focused on the use of mRNA to treat tumors, representing an emerging gene therapy. The use of mRNA can use the expression of some functional proteins for the treatment of genetic disorders or tissue repair, and it can also be applied to immunotherapy through the expression of antigens, antibodies or receptors. Therefore, although these therapies are not fully-fledged enough, they have a broad research prospect. In addition, there are many ways to treat tumors using mRNA vaccines and exosomes carrying mRNA, which have drawn much attention. In this study, we reviewed the current research on the role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors, and examine the future research prospects of mRNA in neural tumors and the opportunities and challenges that will arise in the future application of clinical treatment.
ArticleNumber 49
Audience Academic
Author Zheng, Yiyang
Zhu, Liqing
Kang, Xianhui
Li, Huiting
Huang, Baojun
Zhou, Baofeng
Geng, Wujun
Luo, Yanyan
Chen, Xixi
Author_xml – sequence: 1
  givenname: Yiyang
  surname: Zheng
  fullname: Zheng, Yiyang
– sequence: 2
  givenname: Yanyan
  surname: Luo
  fullname: Luo, Yanyan
– sequence: 3
  givenname: Xixi
  surname: Chen
  fullname: Chen, Xixi
– sequence: 4
  givenname: Huiting
  surname: Li
  fullname: Li, Huiting
– sequence: 5
  givenname: Baojun
  surname: Huang
  fullname: Huang, Baojun
– sequence: 6
  givenname: Baofeng
  surname: Zhou
  fullname: Zhou, Baofeng
– sequence: 7
  givenname: Liqing
  surname: Zhu
  fullname: Zhu, Liqing
– sequence: 8
  givenname: Xianhui
  surname: Kang
  fullname: Kang, Xianhui
– sequence: 9
  givenname: Wujun
  surname: Geng
  fullname: Geng, Wujun
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33673851$$D View this record in MEDLINE/PubMed
BookMark eNp9Uktr3DAYNCWlSbb9Az0UQy89xKneki-FJfQRCAmUPfQmtNLnjRZb2kp2oP--cjZps6EUgSRGM_MxYk6roxADVNVbjM4xVuJjxqRltEEENwhThhv5ojrBTIqG8VYdPbkfV6c5bxHCUkn2qjqmVEiqOD6pfqxuoU6xhzp29fD9eln7UI8Fc3AHfdwNEMaz2nmzCTH7fFaPCcw4o7UJrt6luH-Y5QGmZPp6nIaY8uvqZWf6DG8ezkW1-vJ5dfGtubr5enmxvGosF3RsJLBWAULS2TWyjhpmQfC1pGSNMcMIkFFcMKekEkZiIqRlXSullQY5YHRRXe5tXTRbvUt-MOmXjsbreyCmjTZp9LYH7YhYg2WOG0OYo1QJSwGE7CwoUcYXr097r920HsDZErLkOTA9fAn-Vm_inZYtZRypYvDhwSDFnxPkUQ8-W-h7EyBOWZOSlSmhsCzU98-o2zilUH5KE45Iq1qu2F_WxpQAPnSxzLWzqV4KzgnlbdkW1fk_WGU5GLwtnel8wQ8E754G_ZPwsRaFoPYEm2LOCTpt_WhGH-fcvtcY6bmBet9AXRqo7xuo52DkmfTR_T-i32Kg3FA
CitedBy_id crossref_primary_10_1016_j_jviromet_2024_115040
crossref_primary_10_3389_fimmu_2022_922301
crossref_primary_10_3390_cells12141916
crossref_primary_10_1002_advs_202301789
crossref_primary_10_1021_acsanm_3c05355
crossref_primary_10_1002_wrna_1762
crossref_primary_10_1016_j_jddst_2022_103948
crossref_primary_10_3724_zdxbyxb_2023_0101
crossref_primary_10_1016_j_snb_2022_132631
crossref_primary_10_1016_j_jddst_2022_103288
crossref_primary_10_1016_j_addr_2022_114482
crossref_primary_10_1021_acs_analchem_4c02949
crossref_primary_10_1186_s12885_024_12345_z
crossref_primary_10_1039_D0CS00771D
crossref_primary_10_1097_ot9_0000000000000023
crossref_primary_10_1111_jcmm_70085
crossref_primary_10_1038_s41598_024_71112_z
crossref_primary_10_2147_IJGM_S342611
crossref_primary_10_1021_jacsau_4c00989
crossref_primary_10_1155_2022_2515513
crossref_primary_10_1007_s12272_023_01450_5
crossref_primary_10_1016_j_heliyon_2023_e22383
crossref_primary_10_1021_acs_jmedchem_4c01273
crossref_primary_10_1360_TB_2024_0416
crossref_primary_10_1186_s12860_023_00477_2
crossref_primary_10_3389_fimmu_2022_731516
Cites_doi 10.1007/s00262-013-1453-3.
10.1016/s0955-0674(98)80150-6
10.1093/neuonc/nox027.
10.1053/j.jfas.2008.10.010
10.1021/acsnano.8b07660.
10.1016/j.ccell.2018.11.008
10.1186/s12943-018-0880-3.
10.1080/15548627.2020.1741318.
10.1038/s41467-017-01196-x.
10.1038/s41586-019-0916-x.
10.1038/ng865.
10.3390/cancers12061483
10.1016/j.ccell.2017.03.010.
10.1016/j.canlet.2018.06.041.
10.1002/wrna.1288
10.1215/15228517-2007-035.
10.1038/pr.2013.16.
10.7150/thno.33114.
10.18632/oncotarget.5943
10.1016/j.jtbi.2016.05.026.
10.18632/oncotarget.23946
10.1038/nbt.1807
10.1016/j.omtn.2018.06.004.
10.1038/s41467-019-10,669-0.
10.1146/annurev-biochem-060815-014818
10.1101/cshperspect.a034967
10.1007/s11060-016-2292-9.
10.1126/science.314.5796.34.
10.1038/s41419-017-0129-x.
10.1186/s12935-018-0693-x.
10.1038/onc.2017.351.
10.1016/j.mcna.2019.07.004.
10.1155/2019/7267816
10.1016/S0002-9440(10)64311-8.
10.1016/j.wneu.2019.12.108.
10.1016/j.ajpath.2018.07.017.
10.3389/fonc.2020.550673.
10.1002/pbc.24833.
10.1002/hep.29586.
10.1093/neuonc/noz084.
10.1034/j.1600-079x.2000.280402.x
10.1371/journal.pone.0013445.
10.1186/s13023-019-1223-1.
10.1200/JCO.2017.72.6737.
10.1159/000507759
10.1016/S1474-4422(06)70625-1.
10.1007/s00401-016-1583-8.
10.3892/ol.2020.11299
10.7150/jca.29282.
10.3892/or.2015.3932.
10.1016/j.ccell.2016.11.017.
10.1007/s00401-016-1545-1.
10.15430/JCP.2017.22.4.203
10.1038/ncb1800.
10.3389/fimmu.2018.03053.
10.1016/j.addr.2012.07.002.
10.1093/neuonc/noz065
10.1038/nrd.2017.243
10.1186/s13000-016-0492-4.
10.1016/j.jconrel.2012.04.008.
10.1158/0008-5472.CAN-14-0296.
10.1007/s12519-016-0021-2
10.1016/j.cell.2017.11.031
10.1038/s41417-018-0032-3.
10.1021/acs.accounts.9b00368.
10.1038/nrclinonc.2010.9-c1
10.1016/j.virusres.2017.08.009.
10.1007/s00401-007-0243-4.
10.1038/ncomms7999.
10.1203/PDR.0b013e318163a243.
10.1002/wnan.1530.
10.1158/2159-8290.CD-20-0331
10.1016/j.immuni.2017.11.016
10.1146/annurev-cellbio-100,616-060758.
10.1038/nm0408-373.
10.1097/01.wco.0000053583.70044.ab
10.4161/cc.7.5.5522
10.1007/s00432-018-2796-0
10.1126/science.abc9546
10.1007/s00401-004-0964-6.
10.1016/j.trsl.2016.06.008.
10.1038/nature09267.
10.1038/s41551-019-0485-1.
10.1126/science.1553558.
10.1158/0008-5472.CAN-17-0469.
10.1016/j.otc.2018.07.013.
10.3322/caac.21492
10.1155/2020/6353814
10.1038/nrg3742
10.1016/B978-0-444-53,502-3.00016-1.
10.1038/nrd.2018.71
10.1111/j.1750-3639.1995.tb00590.x
10.1097/WCO.0000000000000755.
10.1007/s11060-020-03401-2
10.1158/2159-8290.CD-19-0399
10.1097/TP.0000000000001834.
10.1111/j.1365-2990.2007.00891.
10.1097/CCO.0000000000000140
10.1016/j.trecan.2018.01.006.
10.1021/acsami.9b17749
10.1007/s00401-014-1247-5.
10.3791/58444
10.3389/fbioe.2020.00177
10.1186/s12957-018-1427-1.
10.1097/NEN.0b013e31829023dd
10.1038/s41467-019-11,911-5.
10.1016/j.addr.2014.12.006
10.1002/glia.10094.
10.1038/sj.onc.1201786
10.1016/j.canlet.2017.08.030.
10.1042/BSR20190045
10.1056/NEJMoa066157.
10.1186/s12967-019-1837-z.
10.1158/2159-8290.CD-16-1292.
10.12659/MSM.918486.
10.1016/j.ctrv.2014.05.004.
10.1186/s12943-020-01171-z.
10.1128/MCB.01532-08.
10.1093/neuonc/nor227.
10.1186/s12977-016-0307-4.
10.1016/j.cps.2019.12.008.
10.17219/acem/81934.
10.1038/s41591-019-0729-3.
10.1172/JCI76739.
10.1038/s42003-020-01306-4.
10.1016/j.ccr.2014.06.014.
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
NPM
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12943-021-01341-7
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic


Publicly Available Content Database
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1476-4598
EndPage 16
ExternalDocumentID oai_doaj_org_article_d26bec4d5aa24d3386c3ee67fce86dcb
PMC7934508
A655235952
33673851
10_1186_s12943_021_01341_7
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
0R~
123
29M
2WC
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PZZ
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
NPM
PMFND
3V.
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c563t-7e498e007dcb0cd3a4ce65b732b11410e0a8564d8786a71267c4f977c7a0de43
IEDL.DBID M48
ISSN 1476-4598
IngestDate Wed Aug 27 01:24:34 EDT 2025
Thu Aug 21 17:49:13 EDT 2025
Fri Jul 11 16:47:12 EDT 2025
Fri Jul 25 02:56:20 EDT 2025
Tue Jun 17 21:09:42 EDT 2025
Tue Jun 10 20:28:15 EDT 2025
Thu Apr 03 07:03:40 EDT 2025
Tue Jul 01 01:01:18 EDT 2025
Thu Apr 24 23:09:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Neural tumor
mRNA
Tumor therapy
Gene regulation
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c563t-7e498e007dcb0cd3a4ce65b732b11410e0a8564d8786a71267c4f977c7a0de43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.proquest.com/docview/2502989584?pq-origsite=%requestingapplication%
PMID 33673851
PQID 2502989584
PQPubID 42702
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_d26bec4d5aa24d3386c3ee67fce86dcb
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7934508
proquest_miscellaneous_2498486817
proquest_journals_2502989584
gale_infotracmisc_A655235952
gale_infotracacademiconefile_A655235952
pubmed_primary_33673851
crossref_citationtrail_10_1186_s12943_021_01341_7
crossref_primary_10_1186_s12943_021_01341_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-03-05
PublicationDateYYYYMMDD 2021-03-05
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-05
  day: 05
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Molecular cancer
PublicationTitleAlternate Mol Cancer
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References M Penco-Campillo (1341_CR65) 2020; 3
H Lee (1341_CR91) 2020; 10
MA Kotterman (1341_CR98) 2014; 15
NR Kapoor (1341_CR108) 2017; 240
MW Neumeister (1341_CR1) 2020; 47
Y Lei (1341_CR85) 2019; 2019
KR Beavers (1341_CR8) 2015; 88
G Steponaitis (1341_CR30) 2019; 10
Z Dong (1341_CR109) 2019; 25
M Giacca (1341_CR99) 2012; 161
R Khajehgoodari (1341_CR94) 2019; 28
1341_CR9
B Li (1341_CR100) 2019; 11
H Zhang (1341_CR106) 2017; 101
EA Obeng (1341_CR13) 2019; 9
R Verbeke (1341_CR14) 2019; 13
AM Quesnel (1341_CR77) 2018; 51
C Dufour (1341_CR46) 2014; 26
EE Dodson (1341_CR76) 2009; 48
A Xiong (1341_CR67) 2020; 12
V Kumar (1341_CR68) 2018; 12
P Milanez-Almeida (1341_CR5) 2020; 26
SG Ahmed (1341_CR83) 2019; 21
EO Vik-Mo (1341_CR116) 2013; 62
N Sonenberg (1341_CR62) 1998; 10
Z Yang (1341_CR101) 2020; 4
1341_CR126
Y Li (1341_CR96) 2014; 26
J Wang (1341_CR37) 2020; 2020
M Fevre-Montange (1341_CR43) 2008; 34
X Fan (1341_CR64) 2003; 162
J July (1341_CR75) 2012; 105
S Wang (1341_CR52) 2017; 408
A Picard (1341_CR74) 2008; 63
D Sun (1341_CR103) 2013; 65
J Rössler (1341_CR72) 2013; 73
SH Lim (1341_CR89) 2014; 40
N Sedaghat (1341_CR56) 2016; 404
H Wang (1341_CR111) 2019; 9
MD Papaioannou (1341_CR39) 2019; 21
I Tsumanuma (1341_CR45) 2000; 28
F Wang (1341_CR57) 2018; 67
A Assunto (1341_CR88) 2019; 14
H Shao (1341_CR113) 2015; 6
P Karras (1341_CR69) 2019; 35
B Vallazza (1341_CR97) 2015; 6
D Khare (1341_CR105) 2018; 9
1341_CR11
Q Yuan (1341_CR92) 2019; 39
Q Tang (1341_CR127) 2019; 11
KS Patel (1341_CR38) 2020; 147
J Li (1341_CR73) 2018; 9
M Breun (1341_CR87) 2020; 19
HC Sass (1341_CR86) 2017; 131
ME Baser (1341_CR35) 2003; 16
D Han (1341_CR26) 2019; 566
KI Ly (1341_CR80) 2019; 103
H Guo (1341_CR12) 2010; 466
A Visvanathan (1341_CR21) 2018; 37
BA Reynolds (1341_CR115) 1992; 255
MJ van den Bent (1341_CR18) 2017; 35
Y Maru (1341_CR71) 1998; 16
Y Xing (1341_CR117) 2016; 177
Z Wei (1341_CR104) 2017; 8
D Dixit (1341_CR22) 2017; 31
J Choi (1341_CR7) 2018; 87
S Hong (1341_CR60) 2017; 22
DN Louis (1341_CR16) 2007; 114
L Alvarez-Erviti (1341_CR102) 2011; 29
L Mao (1341_CR110) 2018; 25
K Terashima (1341_CR48) 2014; 61
MJ Riemenschneider (1341_CR34) 2006; 5
J Skog (1341_CR90) 2008; 10
DA Mitchell (1341_CR118) 2008; 10
R Zheng (1341_CR58) 2018; 17
Y Feng (1341_CR107) 2018; 188
1341_CR27
DN Louis (1341_CR36) 1995; 5
S Fukushima (1341_CR49) 2014; 127
JA Kulkarni (1341_CR10) 2019; 52
J Ma (1341_CR95) 2020; 136
S Yang (1341_CR70) 2019; 10
G Steponaitis (1341_CR32) 2016; 11
J Gojo (1341_CR42) 2017; 19
J Lobo (1341_CR55) 2019; 17
PG Hawkins (1341_CR82) 2008; 7
M Penas-Prado (1341_CR3) 2019; 32
H Lian (1341_CR51) 2018; 4
F Zhang (1341_CR28) 2019; 10
EA Reap (1341_CR122) 2018; 78
JJ Moser (1341_CR33) 2010; 5
EJ Sohn (1341_CR84) 2018; 18
F Bray (1341_CR2) 2018; 68
J El-Saghir (1341_CR59) 2016; 13
J Champier (1341_CR44) 2005; 109
MA Coelho (1341_CR15) 2017; 47
C Prieto (1341_CR63) 2020; 10
MY Armanios (1341_CR19) 2007; 356
KD Meyer (1341_CR50) 2017; 33
VN Barton (1341_CR31) 2013; 72
TN Ignatova (1341_CR114) 2002; 39
T Yu (1341_CR112) 2018; 433
N Pardi (1341_CR123) 2018; 17
RK Datta (1341_CR121) 1975; 65
PA Boriack-Sjodin (1341_CR20) 2018; 17
K Dziurzynski (1341_CR119) 2012; 14
M Bache (1341_CR29) 2015; 33
A Bohlok (1341_CR78) 2018; 16
X Zhang (1341_CR6) 2020; 19
D Dai (1341_CR54) 2018; 9
EC Lai (1341_CR81) 2002; 30
J Chen (1341_CR23) 2019; 145
Z Li (1341_CR24) 2017; 31
J Couzin (1341_CR124) 2006; 314
X Huang (1341_CR47) 2016; 12
A Schulz (1341_CR79) 2016; 132
I Topisirovic (1341_CR61) 2009; 29
R Shao (1341_CR93) 2015; 6
PB Dirks (1341_CR4) 2008; 14
DN Louis (1341_CR17) 2016; 131
FL Liu (1341_CR41) 2020; 8
JE Adair (1341_CR125) 2014; 124
1341_CR40
M Esteller (1341_CR53) 2017; 7
A Schuessler (1341_CR120) 2014; 74
R Su (1341_CR25) 2018; 172
J Yu (1341_CR66) 2020; 83
References_xml – volume: 62
  start-page: 1499
  issue: 9
  year: 2013
  ident: 1341_CR116
  publication-title: Cancer Immunol Immunother
  doi: 10.1007/s00262-013-1453-3.
– volume: 10
  start-page: 268
  issue: 2
  year: 1998
  ident: 1341_CR62
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/s0955-0674(98)80150-6
– volume: 19
  start-page: 1183
  issue: 9
  year: 2017
  ident: 1341_CR42
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/nox027.
– volume: 48
  start-page: 130
  issue: 2
  year: 2009
  ident: 1341_CR76
  publication-title: J Foot Ankle Surg
  doi: 10.1053/j.jfas.2008.10.010
– volume: 13
  start-page: 1655
  issue: 2
  year: 2019
  ident: 1341_CR14
  publication-title: ACS Nano
  doi: 10.1021/acsnano.8b07660.
– volume: 35
  start-page: 46
  issue: 1
  year: 2019
  ident: 1341_CR69
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2018.11.008
– volume: 17
  start-page: 143
  issue: 1
  year: 2018
  ident: 1341_CR58
  publication-title: Mol Cancer
  doi: 10.1186/s12943-018-0880-3.
– ident: 1341_CR40
  doi: 10.1080/15548627.2020.1741318.
– volume: 8
  start-page: 1145
  issue: 1
  year: 2017
  ident: 1341_CR104
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01196-x.
– volume: 566
  start-page: 270
  issue: 7743
  year: 2019
  ident: 1341_CR26
  publication-title: Nature
  doi: 10.1038/s41586-019-0916-x.
– volume: 30
  start-page: 363
  issue: 4
  year: 2002
  ident: 1341_CR81
  publication-title: Nat Genet
  doi: 10.1038/ng865.
– volume: 12
  start-page: 1483
  issue: 6
  year: 2020
  ident: 1341_CR67
  publication-title: Cancers
  doi: 10.3390/cancers12061483
– volume: 31
  start-page: 474
  issue: 4
  year: 2017
  ident: 1341_CR22
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2017.03.010.
– volume: 433
  start-page: 210
  year: 2018
  ident: 1341_CR112
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2018.06.041.
– volume: 6
  start-page: 471
  issue: 5
  year: 2015
  ident: 1341_CR97
  publication-title: Wiley Interdiscip Rev RNA
  doi: 10.1002/wrna.1288
– volume: 65
  start-page: 268
  issue: 9
  year: 1975
  ident: 1341_CR121
  publication-title: J Indian Med Assoc
– volume: 10
  start-page: 10
  issue: 1
  year: 2008
  ident: 1341_CR118
  publication-title: Neuro Oncol
  doi: 10.1215/15228517-2007-035.
– volume: 73
  start-page: 409
  issue: 4 Pt 1
  year: 2013
  ident: 1341_CR72
  publication-title: Pediatr Res
  doi: 10.1038/pr.2013.16.
– volume: 9
  start-page: 5347
  issue: 18
  year: 2019
  ident: 1341_CR111
  publication-title: Theranostics
  doi: 10.7150/thno.33114.
– volume: 6
  start-page: 40507
  issue: 38
  year: 2015
  ident: 1341_CR93
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.5943
– volume: 404
  start-page: 82
  year: 2016
  ident: 1341_CR56
  publication-title: J Theor Biol
  doi: 10.1016/j.jtbi.2016.05.026.
– volume: 9
  start-page: 11948
  issue: 15
  year: 2018
  ident: 1341_CR73
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.23946
– volume: 29
  start-page: 341
  issue: 4
  year: 2011
  ident: 1341_CR102
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.1807
– volume: 12
  start-page: 490
  year: 2018
  ident: 1341_CR68
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1016/j.omtn.2018.06.004.
– volume: 10
  start-page: 2782
  issue: 1
  year: 2019
  ident: 1341_CR70
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-10,669-0.
– volume: 87
  start-page: 421
  year: 2018
  ident: 1341_CR7
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev-biochem-060815-014818
– volume: 10
  start-page: a034967
  issue: 5
  year: 2020
  ident: 1341_CR63
  publication-title: Cold Spring Harb Perspect Med
  doi: 10.1101/cshperspect.a034967
– volume: 131
  start-page: 283
  issue: 2
  year: 2017
  ident: 1341_CR86
  publication-title: J Neurooncol
  doi: 10.1007/s11060-016-2292-9.
– volume: 314
  start-page: 34
  issue: 5796
  year: 2006
  ident: 1341_CR124
  publication-title: Science
  doi: 10.1126/science.314.5796.34.
– volume: 9
  start-page: 124
  year: 2018
  ident: 1341_CR54
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-017-0129-x.
– volume: 18
  start-page: 199
  year: 2018
  ident: 1341_CR84
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-018-0693-x.
– volume: 37
  start-page: 522
  issue: 4
  year: 2018
  ident: 1341_CR21
  publication-title: Oncogene
  doi: 10.1038/onc.2017.351.
– volume: 103
  start-page: 1035
  issue: 6
  year: 2019
  ident: 1341_CR80
  publication-title: Med Clin North Am
  doi: 10.1016/j.mcna.2019.07.004.
– volume: 2019
  start-page: 7267816
  year: 2019
  ident: 1341_CR85
  publication-title: Biomed Res Int
  doi: 10.1155/2019/7267816
– volume: 162
  start-page: 1763
  issue: 6
  year: 2003
  ident: 1341_CR64
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)64311-8.
– volume: 136
  start-page: e196
  year: 2020
  ident: 1341_CR95
  publication-title: World Neurosurg
  doi: 10.1016/j.wneu.2019.12.108.
– volume: 188
  start-page: 2542
  issue: 11
  year: 2018
  ident: 1341_CR107
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2018.07.017.
– volume: 10
  start-page: 550673
  year: 2020
  ident: 1341_CR91
  publication-title: Front Oncol
  doi: 10.3389/fonc.2020.550673.
– volume: 61
  start-page: 593
  issue: 4
  year: 2014
  ident: 1341_CR48
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.24833.
– volume: 67
  start-page: 940
  issue: 3
  year: 2018
  ident: 1341_CR57
  publication-title: Hepatology
  doi: 10.1002/hep.29586.
– volume: 21
  start-page: 1028
  issue: 8
  year: 2019
  ident: 1341_CR39
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/noz084.
– volume: 28
  start-page: 203
  issue: 4
  year: 2000
  ident: 1341_CR45
  publication-title: J Pineal Res
  doi: 10.1034/j.1600-079x.2000.280402.x
– volume: 5
  start-page: e13445
  issue: 10
  year: 2010
  ident: 1341_CR33
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0013445.
– volume: 14
  start-page: 261
  issue: 1
  year: 2019
  ident: 1341_CR88
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/s13023-019-1223-1.
– volume: 35
  start-page: 2394
  issue: 21
  year: 2017
  ident: 1341_CR18
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2017.72.6737.
– volume: 83
  start-page: 242
  issue: 3
  year: 2020
  ident: 1341_CR66
  publication-title: Eur Neurol
  doi: 10.1159/000507759
– volume: 5
  start-page: 1045
  issue: 12
  year: 2006
  ident: 1341_CR34
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(06)70625-1.
– volume: 132
  start-page: 289
  issue: 2
  year: 2016
  ident: 1341_CR79
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-016-1583-8.
– volume: 19
  start-page: 1856
  issue: 3
  year: 2020
  ident: 1341_CR87
  publication-title: Oncol Lett
  doi: 10.3892/ol.2020.11299
– volume: 10
  start-page: 1479
  issue: 6
  year: 2019
  ident: 1341_CR30
  publication-title: J Cancer
  doi: 10.7150/jca.29282.
– volume: 33
  start-page: 3155
  issue: 6
  year: 2015
  ident: 1341_CR29
  publication-title: Oncol Rep
  doi: 10.3892/or.2015.3932.
– volume: 31
  start-page: 127
  issue: 1
  year: 2017
  ident: 1341_CR24
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.11.017.
– volume: 131
  start-page: 803
  issue: 6
  year: 2016
  ident: 1341_CR17
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-016-1545-1.
– volume: 22
  start-page: 203
  issue: 4
  year: 2017
  ident: 1341_CR60
  publication-title: J Cancer Prev
  doi: 10.15430/JCP.2017.22.4.203
– volume: 10
  start-page: 1470
  issue: 12
  year: 2008
  ident: 1341_CR90
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1800.
– volume: 9
  start-page: 3053
  year: 2018
  ident: 1341_CR105
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.03053.
– volume: 65
  start-page: 342
  issue: 3
  year: 2013
  ident: 1341_CR103
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2012.07.002.
– volume: 21
  start-page: 854
  issue: 7
  year: 2019
  ident: 1341_CR83
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/noz065
– volume: 17
  start-page: 261
  issue: 4
  year: 2018
  ident: 1341_CR123
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd.2017.243
– volume: 11
  start-page: 42
  year: 2016
  ident: 1341_CR32
  publication-title: Diagn Pathol
  doi: 10.1186/s13000-016-0492-4.
– volume: 161
  start-page: 377
  issue: 2
  year: 2012
  ident: 1341_CR99
  publication-title: J Contr Release
  doi: 10.1016/j.jconrel.2012.04.008.
– volume: 74
  start-page: 3466
  issue: 13
  year: 2014
  ident: 1341_CR120
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-14-0296.
– volume: 12
  start-page: 275
  issue: 3
  year: 2016
  ident: 1341_CR47
  publication-title: World J Pediatr
  doi: 10.1007/s12519-016-0021-2
– volume: 172
  start-page: 90
  issue: 1–2
  year: 2018
  ident: 1341_CR25
  publication-title: Cell
  doi: 10.1016/j.cell.2017.11.031
– volume: 25
  start-page: 248
  issue: 9–10
  year: 2018
  ident: 1341_CR110
  publication-title: Cancer Gene Ther
  doi: 10.1038/s41417-018-0032-3.
– volume: 52
  start-page: 2435
  issue: 9
  year: 2019
  ident: 1341_CR10
  publication-title: Acc Chem Res
  doi: 10.1021/acs.accounts.9b00368.
– ident: 1341_CR9
  doi: 10.1038/nrclinonc.2010.9-c1
– volume: 240
  start-page: 166
  year: 2017
  ident: 1341_CR108
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2017.08.009.
– volume: 114
  start-page: 97
  issue: 2
  year: 2007
  ident: 1341_CR16
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-007-0243-4.
– volume: 6
  start-page: 6999
  year: 2015
  ident: 1341_CR113
  publication-title: Nat Commun
  doi: 10.1038/ncomms7999.
– volume: 63
  start-page: 263
  issue: 3
  year: 2008
  ident: 1341_CR74
  publication-title: Pediatr Res
  doi: 10.1203/PDR.0b013e318163a243.
– volume: 11
  start-page: e1530
  issue: 2
  year: 2019
  ident: 1341_CR100
  publication-title: Wiley Interdiscip Rev Nanomed Nanobiotechnol
  doi: 10.1002/wnan.1530.
– ident: 1341_CR27
  doi: 10.1158/2159-8290.CD-20-0331
– volume: 47
  start-page: 1083
  issue: 6
  year: 2017
  ident: 1341_CR15
  publication-title: Immunity
  doi: 10.1016/j.immuni.2017.11.016
– volume: 33
  start-page: 319
  year: 2017
  ident: 1341_CR50
  publication-title: Annu Rev Cell Dev Biol
  doi: 10.1146/annurev-cellbio-100,616-060758.
– volume: 14
  start-page: 373
  issue: 4
  year: 2008
  ident: 1341_CR4
  publication-title: Nat Med
  doi: 10.1038/nm0408-373.
– volume: 16
  start-page: 27
  issue: 1
  year: 2003
  ident: 1341_CR35
  publication-title: Curr Opin Neurol
  doi: 10.1097/01.wco.0000053583.70044.ab
– volume: 7
  start-page: 602
  issue: 5
  year: 2008
  ident: 1341_CR82
  publication-title: Cell Cycle
  doi: 10.4161/cc.7.5.5522
– volume: 145
  start-page: 19
  issue: 1
  year: 2019
  ident: 1341_CR23
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-018-2796-0
– ident: 1341_CR11
  doi: 10.1126/science.abc9546
– volume: 109
  start-page: 306
  issue: 3
  year: 2005
  ident: 1341_CR44
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-004-0964-6.
– volume: 177
  start-page: 113
  year: 2016
  ident: 1341_CR117
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2016.06.008.
– volume: 466
  start-page: 835
  issue: 7308
  year: 2010
  ident: 1341_CR12
  publication-title: Nature
  doi: 10.1038/nature09267.
– volume: 4
  start-page: 69
  issue: 1
  year: 2020
  ident: 1341_CR101
  publication-title: Nat Biomed Eng
  doi: 10.1038/s41551-019-0485-1.
– volume: 255
  start-page: 1707
  issue: 5052
  year: 1992
  ident: 1341_CR115
  publication-title: Science
  doi: 10.1126/science.1553558.
– volume: 78
  start-page: 256
  issue: 1
  year: 2018
  ident: 1341_CR122
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-17-0469.
– volume: 51
  start-page: 1179
  issue: 6
  year: 2018
  ident: 1341_CR77
  publication-title: Otolaryngol Clin North Am
  doi: 10.1016/j.otc.2018.07.013.
– volume: 68
  start-page: 394
  issue: 6
  year: 2018
  ident: 1341_CR2
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21492
– volume: 2020
  start-page: 6353814
  year: 2020
  ident: 1341_CR37
  publication-title: Biomed Res Int
  doi: 10.1155/2020/6353814
– volume: 15
  start-page: 445
  issue: 7
  year: 2014
  ident: 1341_CR98
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg3742
– volume: 105
  start-page: 665
  year: 2012
  ident: 1341_CR75
  publication-title: Handb Clin Neurol
  doi: 10.1016/B978-0-444-53,502-3.00016-1.
– volume: 17
  start-page: 435
  issue: 6
  year: 2018
  ident: 1341_CR20
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd.2018.71
– volume: 5
  start-page: 163
  issue: 2
  year: 1995
  ident: 1341_CR36
  publication-title: Brain Pathol
  doi: 10.1111/j.1750-3639.1995.tb00590.x
– volume: 32
  start-page: 895
  issue: 6
  year: 2019
  ident: 1341_CR3
  publication-title: Curr Opin Neurol
  doi: 10.1097/WCO.0000000000000755.
– volume: 147
  start-page: 15
  issue: 1
  year: 2020
  ident: 1341_CR38
  publication-title: J Neurooncol
  doi: 10.1007/s11060-020-03401-2
– volume: 9
  start-page: 1493
  issue: 11
  year: 2019
  ident: 1341_CR13
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-19-0399
– volume: 101
  start-page: 2419
  issue: 10
  year: 2017
  ident: 1341_CR106
  publication-title: Transplantation
  doi: 10.1097/TP.0000000000001834.
– volume: 34
  start-page: 296
  issue: 3
  year: 2008
  ident: 1341_CR43
  publication-title: Neuropathol Appl Neurobiol
  doi: 10.1111/j.1365-2990.2007.00891.
– volume: 26
  start-page: 622
  issue: 6
  year: 2014
  ident: 1341_CR46
  publication-title: Curr Opin Oncol
  doi: 10.1097/CCO.0000000000000140
– volume: 4
  start-page: 207
  year: 2018
  ident: 1341_CR51
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2018.01.006.
– volume: 11
  start-page: 46585
  issue: 50
  year: 2019
  ident: 1341_CR127
  publication-title: ACS Appl Mater Interfaces
  doi: 10.1021/acsami.9b17749
– volume: 127
  start-page: 911
  issue: 6
  year: 2014
  ident: 1341_CR49
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-014-1247-5.
– ident: 1341_CR126
  doi: 10.3791/58444
– volume: 8
  start-page: 177
  year: 2020
  ident: 1341_CR41
  publication-title: Front Bioeng Biotechnol
  doi: 10.3389/fbioe.2020.00177
– volume: 16
  start-page: 125
  issue: 1
  year: 2018
  ident: 1341_CR78
  publication-title: World J Surg Oncol
  doi: 10.1186/s12957-018-1427-1.
– volume: 72
  start-page: 442
  issue: 5
  year: 2013
  ident: 1341_CR31
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/NEN.0b013e31829023dd
– volume: 10
  start-page: 3974
  issue: 1
  year: 2019
  ident: 1341_CR28
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-11,911-5.
– volume: 88
  start-page: 123
  year: 2015
  ident: 1341_CR8
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2014.12.006
– volume: 39
  start-page: 193
  issue: 3
  year: 2002
  ident: 1341_CR114
  publication-title: Glia
  doi: 10.1002/glia.10094.
– volume: 16
  start-page: 2585
  year: 1998
  ident: 1341_CR71
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1201786
– volume: 408
  start-page: 112
  year: 2017
  ident: 1341_CR52
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2017.08.030.
– volume: 39
  start-page: BSR20190045
  issue: 6
  year: 2019
  ident: 1341_CR92
  publication-title: Biosci Rep
  doi: 10.1042/BSR20190045
– volume: 356
  start-page: 1317
  issue: 13
  year: 2007
  ident: 1341_CR19
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa066157.
– volume: 17
  start-page: 79
  issue: 1
  year: 2019
  ident: 1341_CR55
  publication-title: J Transl Med
  doi: 10.1186/s12967-019-1837-z.
– volume: 7
  start-page: 359
  year: 2017
  ident: 1341_CR53
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-16-1292.
– volume: 25
  start-page: 7770
  year: 2019
  ident: 1341_CR109
  publication-title: Med Sci Monit
  doi: 10.12659/MSM.918486.
– volume: 40
  start-page: 857
  year: 2014
  ident: 1341_CR89
  publication-title: Cancer Treat Rev
  doi: 10.1016/j.ctrv.2014.05.004.
– volume: 19
  start-page: 47
  issue: 1
  year: 2020
  ident: 1341_CR6
  publication-title: Mol Cancer
  doi: 10.1186/s12943-020-01171-z.
– volume: 29
  start-page: 1152
  issue: 5
  year: 2009
  ident: 1341_CR61
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.01532-08.
– volume: 14
  start-page: 246
  issue: 3
  year: 2012
  ident: 1341_CR119
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/nor227.
– volume: 13
  start-page: 73
  issue: 1
  year: 2016
  ident: 1341_CR59
  publication-title: Retrovirology
  doi: 10.1186/s12977-016-0307-4.
– volume: 47
  start-page: 279
  issue: 2
  year: 2020
  ident: 1341_CR1
  publication-title: Clin Plast Surg
  doi: 10.1016/j.cps.2019.12.008.
– volume: 28
  start-page: 507
  issue: 4
  year: 2019
  ident: 1341_CR94
  publication-title: Adv Clin Exp Med
  doi: 10.17219/acem/81934.
– volume: 26
  start-page: 188
  issue: 2
  year: 2020
  ident: 1341_CR5
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0729-3.
– volume: 124
  start-page: 4082
  issue: 9
  year: 2014
  ident: 1341_CR125
  publication-title: J Clin Invest
  doi: 10.1172/JCI76739.
– volume: 3
  start-page: 579
  issue: 1
  year: 2020
  ident: 1341_CR65
  publication-title: Commun Biol
  doi: 10.1038/s42003-020-01306-4.
– volume: 26
  start-page: 262
  issue: 2
  year: 2014
  ident: 1341_CR96
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.06.014.
SSID ssj0017874
Score 2.443658
SecondaryResourceType review_article
Snippet Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the nerve,...
Abstract Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 49
SubjectTerms Antigens
Biomarkers
Brain cancer
Cancer
Cancer therapies
Central nervous system
Chemotherapy
Deoxyribonucleic acid
Diagnosis
DNA
DNA methylation
Exosomes
Gene expression
Gene regulation
Gene therapy
Genes
Genetic disorders
Immunotherapy
Medical diagnosis
Messenger RNA
MicroRNAs
Molecular biology
Mortality
mRNA
Mutation
Nervous system
Neural tumor
Prognosis
Proteins
R&D
Radiation therapy
Research & development
Review
Stem cells
Surgery
Tumor therapy
Tumorigenesis
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9RAFH-UgqUX0dpqtMoIBQ9t6Cbz5iPHVSxFaA-lwt6GycwsLtisdHcP_ve-l2TjBkEvXjMzSd68b-Y37wGcSZ98CiqS9YsyR0q_8opEI9chaTPXKfmSLzjf3Orrr_hlpmY7rb4YE9aVB-427jKWmj6DUXlfYqSESgeZ-D0hWR1DzdaXfN42merPD0gMcXtFxurLFXk15PNKTp3Jbudm5Ibaav1_2uQdpzQGTO54oKtn8LQPHcW0--XnsJeaI3jSNZP8eQQHN_0x-QuYEfMF4wbFci4e7m6nYtEIivRE_A0RuhCxQ9ktVhdigJsL30TBmK12gJdzwUv66nrzsHxcHcP91ef7T9d530IhD0rLdW4SVjZRHEA7NQlReiQeqNrIsi4Y4Zkm3iqN0RqrvSlKbQLOKSQMxk9iQnkC-82ySa9AILGU8aaY6orPUj3Wqqx81B4pJ6vLDIrthrrQlxfnLhffXZtmWO06JjhigmuZ4EwG58OaH11xjb_O_sh8GmZyYez2AYmL68XF_UtcMvjAXHasvvR7wfe3EIhILoTlplpRaq4qRQSdjmaS2oXx8FZOXK_2K0fxJFe0p6Aug_fDMK9kKFuTlhuaQxxBq21BBL3sxGogSUpuwqqKDMxI4EY0j0eaxbe2KDjZWaRg-_X_2KQ3cFi2usLQzlPYXz9u0luKvdb1u1bNfgG00yuz
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BEagXBOXRQEFGQuJAo24Sv3JCC6KqkNoDKtLeLMf2wko0KZvdA_-eGcebNkLqdW1r48w3r_jzDMD7ygYbnPBo_XyVc0y_8hqhkUsXpFrKEGxJF5zPL-TZD_5tIRbpg1ufaJU7mxgNte8cfSM_QVdNxcLRX366_pNT1yg6XU0tNO7DAypdRqhWizHhKhCMfHdRRsuTHn0bp1NLSqDReudq4oxizf7_LfMt1zSlTd7yQ6dP4HEKINl8kPhTuBfaA3g4tJT8ewCPztNh-TNYIAQYsQdZt2RX3y_mbNUyjPeYvyEKHTM_cO1W_TEbSefMtp4RcysO0HIqe4n_utledev-OVyefr38cpanRgq5E7La5CrwWgeMBrxrZs5XlqMkRKOqsimI5xlmVgvJvVZaWlWUUjm-xMDQKTvzgVcvYK_t2nAIjKNgiXXKQ1PTiarljShr66XlmJk1ZQbF7oUal4qMU6-L3yYmG1qaQQgGhWCiEIzK4OO45noosXHn7M8kp3EmlceOP3TrnyZpm_GlRGxyL6wtuccsXLoqEPhc0BJfQgYfSMqGlBgfz9l0FwE3SeWwzFwKTNBFLXBDR5OZqHxuOrzDiUnK35sbqGbwbhymlURoa0O3xTkoEa6lLnBDLwdYjVuqKmrFKooM1ARwkz1PR9rVr1gaHK0tx5D71d2P9Rr2y6gFRN08gr3NehveYGy1ad5GBfoHHwMhTQ
  priority: 102
  providerName: ProQuest
Title The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors
URI https://www.ncbi.nlm.nih.gov/pubmed/33673851
https://www.proquest.com/docview/2502989584
https://www.proquest.com/docview/2498486817
https://pubmed.ncbi.nlm.nih.gov/PMC7934508
https://doaj.org/article/d26bec4d5aa24d3386c3ee67fce86dcb
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3raxQxEB_6QPGLaH2d1iOC4Ae7erubx-4Hkau0FOEOKS3ct5BNcnrQ7rb3APvfO5N9tItF8Osl2b3J_CYzszOZAXifGm-8FQ5PP5dGHN2vKEdoRNJ6qebSe5PQBefJVJ6c8-8zMduCtt1Rs4Gre1076id1vrz49Pv65isK_Jcg8Jn8vEKdxSkaSY4xnsqR2oZd1EyKOhpM-G1UAcEZosxcyYiLPGsv0dz7jJ6iCvX8_z6176itfkrlHR11_AQeN8YlG9doeApbvtyDB3W7yZs9eDhpAunPYIbwYJRZyKo5uzydjtmiZGgLMnebRHTAXJ2Ht1gdsC4hnZnSMcrqCgO0nEpi4lvXm8tquXoOZ8dHZ99OoqbJQmSFTNeR8jzPPFoKzhYj61LDkUuiUGlSxJQD6kcmE5K7TGXSqDiRyvI5Go1WmZHzPH0BO2VV-lfAODKdMlK5L3KKthpeiCQ3ThqOXluRDCBuN1TbpgA59cG40MERyaSumaCRCTowQasBfOzWXNXlN_45-5D41M2k0tnhh2r5UzeSqF0iEbfcCWMS7tBDlzb1BEzrM4mbMIAPxGVNkMO_Z01zTwGJpFJZeiwFOu8iF0jQfm8mCqbtD7c40S2uNVqcVPMezb4BvOuGaSUlu5W-2uAc5AjPZBYjQS9rWHUkpSm1aRXxAFQPcD2a-yPl4lcoG44nMUdz_PV_bekbeJQEoaAsz33YWS83_i2aYetiCNtqpoawe3g0_XE6DB8zhkHe_gAQfC17
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VIh4XBIXCQgEjgTjQVbNer705IBQeVUqbHFCQcrO8tgOR6G7JJkL9UfxHZvbVrpB66zW2E4_n5Ym_mQF4HRtvvE0cWj8XhwLDr3CIohFK66VaSO8NpwTnyVSOv4uv82S-BX_bXBiCVbY2sTLUrrD0H_kBumoqFo7-8sPZ75C6RtHrattCoxaLY3_-B0O28v3RZ-TvG84Pv8w-jcOmq0BoExmvQ-XFMPXoGp3NBtbFRuC2kkzFPIsI9OgHJk2kcKlKpVERl8qKBd6SrDID50WMX3sDbqLfHVCsp-ZdfBeh7Is2LyeVByW6UkGPpBSvo7MIVc_3VS0C_ncElzxhH6V5ye0d3od7zX2VjWoBewBbPt-BW3UHy_MduD1p3uYfwhwljhFYkRULdvptOmLLnOH1krkLXNI-czW0b1nusw7jzkzuGAHFqgFaTlU28VfXm9NiVT6C2XWc8C5s50XunwATKEcEchU-G9IDrhFZwofGSSMwEMx4AFF7oNo2Nc2ptcYvXcU2qdQ1EzQyQVdM0CqAd92as7qix5WzPxKfuplUjbv6oFj90I1ya8clqoJwiTFcOAz6pY09ybr1qcRDCOAtcVmTzcDtWdOkPiCRVH1Lj2SScMqQRoL2ejNR121_uJUT3diaUl9oRgCvumFaSfi53BcbnIMcEalMIyTocS1WHUlxTJ1fkygA1RO4Hs39kXz5s6pEjsZd4A3_6dXbegl3xrPJiT45mh4_g7u80ghCje7B9nq18c_xWrfOXlTKxEBfs_L-A2uoXMY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+mRNA+in+the+development%2C+diagnosis%2C+treatment+and+prognosis+of+neural+tumors&rft.jtitle=Molecular+cancer&rft.au=Zheng%2C+Yiyang&rft.au=Luo%2C+Yanyan&rft.au=Chen%2C+Xixi&rft.au=Li%2C+Huiting&rft.date=2021-03-05&rft.issn=1476-4598&rft.eissn=1476-4598&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12943-021-01341-7&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12943_021_01341_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-4598&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-4598&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-4598&client=summon